Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fast-MRI could spot liver cancer earlier than ultrasound alone

NCT ID NCT05095714

Recruiting now Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares adding a quick MRI scan (fast-MRI) to standard ultrasound every six months for detecting early-stage liver cancer in people with cirrhosis who are at high risk. About 944 participants will be randomly assigned to either ultrasound alone or ultrasound plus fast-MRI. The goal is to see if the combined approach finds more early cancers and is cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Liver fast-MRI scan
What this could lead to
If successful, this could make fast-MRI the standard screening tool for early liver cancer in high-risk patients, catching more cancers at a curable stage.
What could go wrong
This is a Phase NA study, so results are not yet proven. Fast-MRI is more expensive and may not be cost-effective or widely available. The trial is still recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis liver cancer liver disorder Liver Neoplasms hepatocellular carcinoma prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LIVER DISEASE CIRRHOSIS HEPATOCELLULAR CARCINOMA LIVER CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Assistance Publique Hôpitaux de Paris - Hôpital Avicenne

    RECRUITING

    Bondy, 93140, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.